LETRONAT 2.5MG

Letronat 2.5mg Tablet is an anticancer medication that contains letrozole as its active ingredient and falls under the category of aromatase inhibitors. It is recommended as a supportive treatment following the primary therapy or as a first-line option for postmenopausal women diagnosed with early and advanced breast cancer, particularly those with hormone receptor-positive tumors. Given that elevated estrogen levels are known to trigger breast cancer, this medication works by lowering the levels of this female reproductive hormone through the inhibition of the enzyme aromatase, which plays a crucial role in estrogen production. The primary goal of this treatment is to slow down or halt the growth and/or metastasis of cancer to other areas of the body.

It is important to inform your healthcare provider if you have not yet reached menopause, as this medication is ineffective for premenopausal women. Due to its tendency to lower female reproductive hormone levels, it is not recommended for menstruating women, as it may lead to fertility complications. Additionally, it is advisable to monitor your cholesterol levels, as this medication can increase them. Letronat 2.5mg Tablet may also lead to a decrease in bone mineral density. Therefore, it is essential to discuss this with your physician and consider regular monitoring of your bone health. Effective birth control is recommended during the treatment period and for at least three weeks following the final dose.